Elixinol Wellness Limited
ELLXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 80.9% | 17.2% | -24.4% | – |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | 37.7% | 41.4% | -46.3% | -67% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -27.4% | -82.3% | -131.6% | -161.9% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -11.5% | -90.8% | -149.8% | -182.3% |
| EPS Diluted | -0.011 | -0.099 | -0.026 | -0.042 |
| % Growth | 88.8% | -280.4% | 38.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |